Piramal Pharma Solutions announced on March 26 the installation of a Korsch X3 tablet press at its Morpeth facility in the United Kingdom, marking the site’s 20th anniversary. The company said this addition is part of its ongoing efforts to enhance pharmaceutical manufacturing capabilities.
The announcement highlights Piramal Pharma Solutions’ commitment to advancing production technology and supporting patient needs. The Korsch X3, equipped with a specialized DryCon containment kit, is expected to help accelerate the availability of vital therapies.
According to the company, the acquisition underscores both expertise and leadership in pharmaceutical manufacturing at Morpeth. The facility serves as an integrated development and manufacturing site for active pharmaceutical ingredients (APIs) and oral solid dosage forms.
The press release was distributed by PR Newswire, which operates in more than 170 countries and supports communications in over 40 languages, according to the official website. PR Newswire aims to deliver global reach for press release distribution through its network of newsrooms and influencers, as detailed on the official website. The service features expert editors with over a decade of experience providing round-the-clock support and search engine optimization guidance, according to the official website. It also collaborates with more than 500,000 media outlets and influencers worldwide, as noted on its official website. In addition to distributing press releases, PR Newswire offers services such as AI-enhanced content tools and social sharing features outlined on its official website.
As Piramal Pharma Solutions celebrates two decades at Morpeth with new technology investments, industry observers may look for further developments aimed at strengthening pharmaceutical production capabilities.
